Sherman Lin (@pathshermanoma) 's Twitter Profile
Sherman Lin

@pathshermanoma

MD Student | Views my own. T/RT โ‰  advice. Avid Fisherman, Foodie, #pathnerd.

ID: 1330409628061085696

calendar_today22-11-2020 07:16:12

66 Tweet

165 Followers

141 Following

Matthew Cecchini MD PhD FRCPC (@path_matt) 's Twitter Profile Photo

So amazing!!! we already have almost 70 staff pathologists signed on to the project! There is still room to join what will hopefully be the largest consensus driven classification of mitotic figures. Send me a message if you want to join. Letโ€™s see if we can get to 100!

Matthew Cecchini MD PhD FRCPC (@path_matt) 's Twitter Profile Photo

The power of social media is truly amazing! We have assembled a global group of pathologists to generate an international consensus of 1000 mitotic figures. Send me a message if you want to participate! Thanks to the awesome work of Sherman Lin for leading this project.

The power of social media is truly amazing! 
We have assembled a global group of pathologists to generate an international consensus of 1000 mitotic figures.
Send me a message if you want to participate! 
Thanks to the awesome work of <a href="/PathShermanoma/">Sherman Lin</a> for leading this project.
Tim Kendall (@timkendall_path) 's Twitter Profile Photo

International #LiverPath, if you report cholangiocarcinoma, do you want to inform consensus histopath guidelines? EURO-CHOLANGIO-NET ENS-CCA colleagues and I would value your opinions via a short survey. Message me on Twitter if interested & please share.

International #LiverPath, if you report cholangiocarcinoma, do you want to inform consensus histopath guidelines? <a href="/CholangioNet/">EURO-CHOLANGIO-NET</a> <a href="/CcaEns/">ENS-CCA</a> colleagues and I would value your opinions via a short survey. Message me on Twitter if interested &amp; please share.
Sherman Lin (@pathshermanoma) 's Twitter Profile Photo

Very excited to announce that our 1000 mitotic figures project was accepted at #USCAP2023! I am very fortunate to learn from the amazing mentor Matthew Cecchini MD PhD FRCPC and the brilliant pathologists that I met through this study. I hope to meet all of you at New Orleans next year! ๐Ÿ˜

Very excited to announce that our 1000 mitotic figures project was accepted at #USCAP2023! I am very fortunate to learn from the amazing mentor <a href="/Path_Matt/">Matthew Cecchini MD PhD FRCPC</a> and the brilliant pathologists that I met through this study. I hope to meet all of you at New Orleans next year! ๐Ÿ˜
Matthew Cecchini MD PhD FRCPC (@path_matt) 's Twitter Profile Photo

Our study lead by the awesome Sherman Lin is an example of how #pathtwitter can be used to solve complex problems with the combined efforts of many individuals around the world. We are excited to share the results of this study at #USCAP2023

Our study lead by the awesome <a href="/PathShermanoma/">Sherman Lin</a> is an example of how #pathtwitter can be used to solve complex problems with the combined efforts of many individuals around the world. We are excited to share the results of this study at #USCAP2023
Sherman Lin (@pathshermanoma) 's Twitter Profile Photo

Excited to finally share my first (first author) paper in Modern Pathology showing tumor cellularity as a prognostic feature in lung cancer. Shout out to my amazing mentors Matthew Cecchini MD PhD FRCPC and Irene Sansano, MD Phd who introduced me to the endless possibilities using computational methods!

#nicholslab (@nicholslab1) 's Twitter Profile Photo

Humbled and grateful to receive a 5 year CIHR-ICR | IC-IRSC grant to study novel targeted and immunotherapy combinations in anaplastic thyroid cancer! Time to get to work!!!! Ranked 2/39 on the panel a lab best! Western Schulich MD/PhD Schulich WesternU London Health Sciences Centre Peter Zeng

Sanjay Mukhopadhyay (@smlungpathguy) 's Twitter Profile Photo

Truly making a difference as a pathologist: reporting a positive ALK stain in lung adenocarcinoma: Why? Chances are that you have directly impacted choice of targeted therapy. Images: ALK (D5F3)... kikoxp.com/posts/22222

Truly making a difference as a pathologist: reporting a positive ALK stain in lung adenocarcinoma: Why? Chances are that you have directly impacted choice of targeted therapy. Images: ALK (D5F3)... kikoxp.com/posts/22222
Sherman Lin (@pathshermanoma) 's Twitter Profile Photo

Thank you for sharing the word Swikrity U Baskota,MD, FCAP,FASCP! Iโ€™m really looking forward to sharing our work and meeting with co-authors in person. This project is a shining example of how teamwork makes the dream work ๐Ÿ˜

Arch Pathol Lab Med (@archivespath) 's Twitter Profile Photo

๐Ÿ“ข Study showing the ability of ChatGPT to answer questions at a level similar to or exceeding a trained pathologist! ๐Ÿค– - highlighting the potential of algorithmic language models to assist pathologists & enhance #PathResidents education #PathTwitter doi.org/10.5858/arpa.2โ€ฆ

๐Ÿ“ข Study showing the ability of ChatGPT to answer questions at a level similar to or exceeding a trained pathologist! ๐Ÿค– - highlighting the potential of algorithmic language models to assist pathologists &amp; enhance #PathResidents education #PathTwitter doi.org/10.5858/arpa.2โ€ฆ
Sherman Lin (@pathshermanoma) 's Twitter Profile Photo

Thrilled to share our paper on the largest international study on mitotic figures with 85 global pathologists! Grateful to all of our co-authors for your belief and expertise in the study. Thank you for making this work possible! ๐Ÿ˜